Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy

Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam

(2014) Nguyen Thi Ngoc Lan et al.   PLoS One

Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy

(2013) Junko Tanuma et al.   PLoS One

Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin

(2012) Kelly E. Dooley et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

(2012) Ravindra K Gupta et al.   LANCET

Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa

(2012) Richard A. Murphy et al.   PLoS One

Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis

(2011) François-Xavier Blanc et al.   NEW ENGLAND JOURNAL OF MEDICINE

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

(2011) Diane V. Havlir et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacokinetics of Darunavir/Ritonavir and Rifabutin Coadministered in HIV-Negative Healthy Volunteers

(2010) V. Sekar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

(2010) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifamycin‐ResistantMycobacterium tuberculosisin the Highly Active Antiretroviral Therapy Era: A Report of 3 Relapses with Acquired Rifampin Resistance following Alternate‐Day Rifabutin and Boosted Protease Inhibitor Therapy

(2009) Elizabeth R. Jenny‐Avital et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis

(2009) Catherine Boulanger et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection

(2009) H. Khachi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY